Clinical evolution

MENA emerging as trial destination says ClinTec CEO

MENA emerging as trial destination says ClinTec CEO

By Gareth Macdonald

Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.

Ethical standards key to CEE CRO sector growth, says EastHorn

Ethical standards key to CEE CRO sector growth, says EastHorn

By Gareth Macdonald

Malgorzata Szerszeniewska, CEO of Central and Eastern Europe’s (CEE) “newest” CRO EastHorn, says maintaining ethical standards is crucial to sustaining the rapid patient recruitment rates that characterise the region.

Icon eyeing China

Icon eyeing China

By Nick Taylor

Icon is looking to expand its bioanalytical capacity in Asia, notably in China, and bolster its genomics, proteomics and cell-based assay capabilities, according to a VP who discussed diversification of the business.